138 related articles for article (PubMed ID: 16440431)
1. Influence of HBcAg in liver cell plasma on expression of transforming growth factor-beta 1 in liver tissue of low-grade chronic hepatitis B patients.
Liu YG; Lu JH; Wang XX; Yang JL; Lang ZW; Meng X; Zhang LJ; Sun L; Zhang SJ; Li JQ; Song CZ
World J Gastroenterol; 2006 Jan; 12(1):127-9. PubMed ID: 16440431
[TBL] [Abstract][Full Text] [Related]
2. In situ expression of transforming growth factor-beta1-3, latent transforming growth factor-beta binding protein and tumor necrosis factor-alpha in liver tissue from patients with chronic hepatitis C.
Kinnman N; Andersson U; Hultcrantz R
Scand J Gastroenterol; 2000 Dec; 35(12):1294-300. PubMed ID: 11199370
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of HBsAg and HBcAg in hepatocytes in chronic hepatitis B].
Wang GS; Wang MM; Xie QL; Ming L; Jiang XN; Chen LW; Liu MH
Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):287-9. PubMed ID: 15161505
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of intrahepatic hepatitis B core antigen (+) in patients with chronic hepatitis B].
Pan HY; Zhang YL; Chen CR; Wang J; Li BR; Lu DR; Lou GQ; Shi JP
Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):582-4. PubMed ID: 17711626
[TBL] [Abstract][Full Text] [Related]
5. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
6. [Role of transforming growth factor beta1 (TGF-beta1) in the pathogenesis and clinical course of chronic hepatitis in children].
Liberek A; Marek A; Kmieć Z; Kartanowicz D; Szlagatys-Sidorkiewicz A; Łuczak G; Wierzbicki PM; Stanisławowski M; Wierzbicki M; Marek K; Liberek T; Sikorska-Wiśniewska G; Góra-Gebka M; Wegrzyn G; Kamińska B
Med Wieku Rozwoj; 2009; 13(3):163-70. PubMed ID: 20081261
[TBL] [Abstract][Full Text] [Related]
7. [Expressive features of HBsAg and HBcAg in the livers of chronic hepatitis B and its clinical significance].
Le XH; Chen XC; Lin Q; Li MZ; Wang M; Liu SY; Yu ZY; Zhou BP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):41-3. PubMed ID: 17429532
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
[TBL] [Abstract][Full Text] [Related]
9. Core antigen expression is associated with hepatic necroinflammation in e antigen-negative chronic hepatitis B patients with low DNA loads.
Huang YH; Hung HH; Chan CC; Lai CR; Chu CJ; Huo TI; Lee PC; Su CW; Lan KH; Huang HC; Lee IC; Lin HC; Lee SD
Clin Vaccine Immunol; 2010 Jun; 17(6):1048-53. PubMed ID: 20427626
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
[TBL] [Abstract][Full Text] [Related]
11. Negative HBcAg in immunohistochemistry assay of liver biopsy is a predictive factor for the treatment of patients with nucleos(t)ide analogue therapy.
Huang M; Liu J; Chow M; Zhou X; Han Z; He Z; Xue J; Zhu Z; Li X; Xia J
J Cell Mol Med; 2018 Mar; 22(3):1675-1683. PubMed ID: 29193766
[TBL] [Abstract][Full Text] [Related]
12. HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients.
Li J; Wu W; Peng G; Chen F; Bai M; Zheng M; Chen Z
Immunol Cell Biol; 2010; 88(8):834-41. PubMed ID: 20498672
[TBL] [Abstract][Full Text] [Related]
13. Identification of hepatitis B virus-DNA in the liver by in situ hybridization using a biotinylated probe. Relation to HBcAg expression and histology.
Naoumov NV; Daniels HM; Davison F; Eddleston AL; Alexander GJ; Williams R
J Hepatol; 1993 Sep; 19(2):204-10. PubMed ID: 8301053
[TBL] [Abstract][Full Text] [Related]
14. Correlation between hepatic hepatitis B core antigen and serum hepatitis B virus-DNA levels in patients with chronic hepatitis B virus infections in Taiwan.
Wu JC; Lee SD; Wang JY; Ting LP; Tsai YT; Tsay SH; Tong MJ
Arch Pathol Lab Med; 1987 Feb; 111(2):181-4. PubMed ID: 3545139
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B: The interplay between intrahepatic lymphocyte population and viral antigens in relation to liver damage.
Giadans CG; Ríos DA; Ameigeiras B; Pietrantonio AM; Lucatelli NL; Haddad L; Mullen E; Heinrich F; De Matteo E; Flichman D; Valva P; Preciado MV
J Viral Hepat; 2019 Jun; 26(6):727-737. PubMed ID: 30739377
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
Zhu R; Zhang HP; Yu H; Li H; Ling YQ; Hu XQ; Zhu HG
Pathol Res Pract; 2008; 204(10):731-42. PubMed ID: 18597951
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver.
Hsia CC; Axiotis CA; Di Bisceglie AM; Tabor E
Cancer; 1992 Sep; 70(5):1049-56. PubMed ID: 1325266
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
[TBL] [Abstract][Full Text] [Related]
19. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
20. Change of intrahepatic expression of hepatitis-B core antigen during the clinical course of type-B chronic hepatitis.
Franca ST; Kiyosawa K; Imai Y; Sodeyama T; Hayata T; Nakano Y; Nakamura M; Furuta S
Scand J Gastroenterol; 1989 May; 24(4):454-60. PubMed ID: 2675303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
